Le QT - Search Results

1

Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines.

Grégoire V, Evans M, Le QT, Bourhis J, Budach V, Chen A, Eisbruch A, Feng M, Giralt J, Gupta T, Hamoir M, Helito JK, Hu C, Hunter K, Johansen J, Kaanders J, Laskar SG, Lee A, Maingon P, Mäkitie A, Micciche' F, Nicolai P, O'Sullivan B, Poitevin A, Porceddu S, Składowski K, Tribius S, Waldron J, Wee J, Yao M, Yom SS, Zimmermann F, Grau C. Grégoire V, et al. Among authors: le qt. Radiother Oncol. 2018 Jan;126(1):3-24. doi: 10.1016/j.radonc.2017.10.016. Epub 2017 Nov 24. Radiother Oncol. 2018. PMID: 29180076

2

Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma.

Daly ME, Lieskovsky Y, Pawlicki T, Yau J, Pinto H, Kaplan M, Fee WE, Koong A, Goffinet DR, Xing L, Le QT. Daly ME, et al. Among authors: le qt. Head Neck. 2007 Mar;29(3):211-20. doi: 10.1002/hed.20505. Head Neck. 2007. PMID: 17111429

3

Plasma osteopontin is an independent prognostic marker for head and neck cancers.

Petrik D, Lavori PW, Cao H, Zhu Y, Wong P, Christofferson E, Kaplan MJ, Pinto HA, Sutphin P, Koong AC, Giaccia AJ, Le QT. Petrik D, et al. Among authors: le qt. J Clin Oncol. 2006 Nov 20;24(33):5291-7. doi: 10.1200/JCO.2006.06.8627. J Clin Oncol. 2006. PMID: 17114663

4

Nasopharyngeal and oropharyngeal carcinomas: target delineation, therapy delivery and stereotactic boost procedures with intensity-modulated/ image-guided radiation therapy.

Le QT. Le QT. Front Radiat Ther Oncol. 2007;40:208-231. doi: 10.1159/000106037. Front Radiat Ther Oncol. 2007. PMID: 17641511 Review.

5

Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: clinical outcomes and patterns of failure.

Daly ME, Le QT, Maxim PG, Loo BW Jr, Kaplan MJ, Fischbein NJ, Pinto H, Chang DT. Daly ME, et al. Among authors: le qt. Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1339-46. doi: 10.1016/j.ijrobp.2009.04.006. Epub 2009 Jun 18. Int J Radiat Oncol Biol Phys. 2010. PMID: 19540068

6

Intensity-modulated radiotherapy for oral cavity squamous cell carcinoma: patterns of failure and predictors of local control.

Daly ME, Le QT, Kozak MM, Maxim PG, Murphy JD, Hsu A, Loo BW Jr, Kaplan MJ, Fischbein NJ, Chang DT. Daly ME, et al. Among authors: le qt. Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1412-22. doi: 10.1016/j.ijrobp.2010.04.031. Epub 2010 Aug 2. Int J Radiat Oncol Biol Phys. 2011. PMID: 20675073

7

Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.

Rischin D, Young RJ, Fisher R, Fox SB, Le QT, Peters LJ, Solomon B, Choi J, O'Sullivan B, Kenny LM, McArthur GA. Rischin D, et al. Among authors: le qt. J Clin Oncol. 2010 Sep 20;28(27):4142-8. doi: 10.1200/JCO.2010.29.2904. Epub 2010 Aug 9. J Clin Oncol. 2010. PMID: 20697079 Free PMC article. Clinical Trial.

8

Correlation between metabolic tumor volume and pathologic tumor volume in squamous cell carcinoma of the oral cavity.

Murphy JD, Chisholm KM, Daly ME, Wiegner EA, Truong D, Iagaru A, Maxim PG, Loo BW Jr, Graves EE, Kaplan MJ, Kong C, Le QT. Murphy JD, et al. Among authors: le qt. Radiother Oncol. 2011 Dec;101(3):356-61. doi: 10.1016/j.radonc.2011.05.040. Epub 2011 Jun 12. Radiother Oncol. 2011. PMID: 21665308 Free PMC article.

9

Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study.

Le QT, Kim HE, Schneider CJ, Muraközy G, Skladowski K, Reinisch S, Chen Y, Hickey M, Mo M, Chen MG, Berger D, Lizambri R, Henke M. Le QT, et al. J Clin Oncol. 2011 Jul 10;29(20):2808-14. doi: 10.1200/JCO.2010.32.4095. Epub 2011 Jun 13. J Clin Oncol. 2011. PMID: 21670453 Clinical Trial.

10

Prognostic and predictive significance of plasma HGF and IL-8 in a phase III trial of chemoradiation with or without tirapazamine in locoregionally advanced head and neck cancer.

Le QT, Fisher R, Oliner KS, Young RJ, Cao H, Kong C, Graves E, Hicks RJ, McArthur GA, Peters L, O'Sullivan B, Giaccia A, Rischin D. Le QT, et al. Clin Cancer Res. 2012 Mar 15;18(6):1798-807. doi: 10.1158/1078-0432.CCR-11-2094. Epub 2012 Mar 1. Clin Cancer Res. 2012. PMID: 22383739 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

478 results

Search Page

Filters